> SIRION Biotech
SIRION Biotech
SIRION Biotech GmbH has been operating for 7 years as a specialized service provider for preclinical target research. Using proprietary viral vector and RNAi technologies SIRION`s customized cell models offer access to in depth functional gene analysis, thereby improving target identification/ validation and compound screening in a variety of industries. Their technologies have also been successfully used for primary cell immortalizations. Moreover, novel viral vectors for gene therapy and vaccine applications are under development.

SIRION’s track record is supported and validated by over 300 commercial projects with more than 70 clients worldwide. Located at one of Europe`s most attractive hot spots in the Biotech industries, the “Innovation and Startup Center for Biotechnology” (IZB) near Munich/ Bavaria, SIRION drives leading scientific collaboration to refine technologies.

Powered by: